[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @m72068958 다율잉(DaYule) 다율잉(DaYule) posts on X about $crsp, crispr, files, vivo the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1310244506969583617/interactions)  - X Week XXX -XX% - X Months XXXXX -XX% - X Year XXXXXX +1,114% ### Mentions: X [#](/creator/twitter::1310244506969583617/posts_active)  - X Week X no change - X Months X -XX% - X Year XX +329% ### Followers: XX [#](/creator/twitter::1310244506969583617/followers)  - X Week XX +3.70% - X Month XX +17% - X Months XX +30% ### CreatorRank: undefined [#](/creator/twitter::1310244506969583617/influencer_rank)  ### Social Influence [#](/creator/twitter::1310244506969583617/influence) --- **Social category influence** [technology brands](/list/technology-brands) **Social topic influence** [$crsp](/topic/$crsp) #24, [crispr](/topic/crispr) #16, [files](/topic/files), [vivo](/topic/vivo), [future of](/topic/future-of), [targets](/topic/targets) **Top assets mentioned** [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) ### Top Social Posts [#](/creator/twitter::1310244506969583617/posts) --- Top posts by engagements in the last XX hours "$CRSP files patent for SyNTase (US 99421485) Evolving into a next-generation in vivo gene-editing platform company. With proof-of-concept data showing up to XX% editing efficiency SyNTase could redefine the future of gene therapy. Watch #CRSP. #CRISPR #SyNTase #GeneEditing" [X Link](https://x.com/m72068958/status/1974273962910925090) [@m72068958](/creator/x/m72068958) 2025-10-04T00:42Z XX followers, 1721 engagements "1. Big moment for $CRSP. CRISPR Therapeutics just presented new preclinical data for CTX460 the first candidate from its SyNTase gene editing platform at #ESGCT2025. It targets Alpha-1 Antitrypsin Deficiency (AATD) a rare liver & lung disease with no curative options" [X Link](https://x.com/m72068958/status/1976619928737435660) [@m72068958](/creator/x/m72068958) 2025-10-10T12:04Z XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
다율잉(DaYule) posts on X about $crsp, crispr, files, vivo the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social category influence technology brands
Social topic influence $crsp #24, crispr #16, files, vivo, future of, targets
Top assets mentioned CRISPR Therapeutics AG (CRSP)
Top posts by engagements in the last XX hours
"$CRSP files patent for SyNTase (US 99421485) Evolving into a next-generation in vivo gene-editing platform company. With proof-of-concept data showing up to XX% editing efficiency SyNTase could redefine the future of gene therapy. Watch #CRSP. #CRISPR #SyNTase #GeneEditing"
X Link @m72068958 2025-10-04T00:42Z XX followers, 1721 engagements
"1. Big moment for $CRSP. CRISPR Therapeutics just presented new preclinical data for CTX460 the first candidate from its SyNTase gene editing platform at #ESGCT2025. It targets Alpha-1 Antitrypsin Deficiency (AATD) a rare liver & lung disease with no curative options"
X Link @m72068958 2025-10-10T12:04Z XX followers, XXX engagements
/creator/twitter::m72068958